Vox Markets Logo

Open Orphan New Clinic, eEnergy Trading Update and Glen Goodman on Bitcoin, Ethereum & Dogecoin

14:16, 4th February 2021

AudioBoom Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: Open Orphan New Clinic, eEnergy Trading Update and Glen Goodman on Bitcoin, Ethereum & Dogecoin

Cathal Friel, Executive Chairman of Open Orphan #ORPH FOLLOW talks about their new challenge study quarantine clinic they've just opened in East London.

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility.


Harvey Sinclair, CEO of eEnergy #EAAS FOLLOW discusses their pre-close Trading Update, which shows triple digit percentage gain on revenue.

eEnergy Group plc is a leading "Energy Efficiency-as-a-Service" (EEaaS) business focused on providing its core "Light-as-a-Service" ("LaaS"), to educational and commercial & industrial customers through its eLight and RSL operations in the UK and Ireland. The Group helps businesses and schools switch to LED lighting, typically for a fixed monthly service fee, avoiding any upfront payments.

(Interview starts at 8 minutes 12 seconds)


Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", talks about Elon Musk's crypto pumping, Jeff Bezos, Bitcoin, Ethereum & Dogecoin

(Interview starts at 15 minutes 3 seconds)

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist